Not all mismatches are equal: importance of alloreactivity direction

by Jacinta Perram, Nada Hamad
Published 2021-08-01

The Application of the Homotopy Analysis Method and the Homotopy Perturbation Method to the Davey-Stewartson Equations and Comparison between Them and Exact Solutions

by Hassan A. Zedan, W. Barakati, Nada Hamad
Published 2013-01-01

INFLUENCE OF STEEL FIBRES OF CRIMPED AND HOOKED-END SHAPE ON THE MECHANICAL PROPERTIES OF PORTLAND CEMENT

by Nada Hamad Khalaf, Saheb M. Mahdi, Yasir Khalil Ibrahim
Published 2024-05-01

Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease

by Adrian Peacock, Frances C. Dehle, Oscar A. Mesa Zapata, Francesca Gennari, Maro R.I. Williams, Nada Hamad, Stephen Larsen, Simon J. Harrison, Colman Taylor
Published 2024-02-01

Pregnancy associated cancer, timing of birth and clinical decision making—a NSW data linkage study

by Nadom Safi, Zhuoyang Li, Antoinette Anazodo, Marc Remond, Andrew Hayen, David Currow, David Roder, Nada Hamad, Michael Nicholl, Adrienne Gordon, Jane Frawley, Penelope Fotheringham, Elizabeth Sullivan
Published 2023-02-01

S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES

by Michael Dickinson, Nada Hamad, Christian Bryant, Nishi Kothari, Paulius Ojeras, Anmol Vohra, Ming Lin, Mira Tohme, James Trager, David Shook, Glen Kennedy, Michael Tees, Brian T. Hill
Published 2023-08-01

Use of lactoferrin supplement as an efficient antioxidant to ameliorate the effects of mercury-induced oxidative stress in male wistar rats

by Mohammed Mousa Al Zharani, Eman Abdullah Almuqri, Mohammed Mubarak Ahmed, Nada Hamad Aljarba, Hassan Ahmed Rudayni, Khadija Nasser Yaseen, Saad Hussin Alkahtani, Fahd Ahmed Nasr, Amin Abdullah Al Doaiss, Mohammed Saad Al eissa
Published 2024-01-01

COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers

by Nathan Bain, Mike Nguyen, Lisa Grech, Daphne Day, Amelia McCartney, Kate Webber, Alastair Kwok, Sam Harris, Hieu Chau, Bryan Chan, Louise Nott, Nada Hamad, Annette Tognela, Craig Underhill, Bao Sheng Loe, Daniel Freeman, Eva Segelov, on behalf of the CANVACCS Investigators
Published 2022-08-01

Utility of KRAS Gene and Clinicopathological Features in the Assessment of the Risk of Type 2 Diabetes in the Etiology of Colon Cancer

by Wedad Saeed Al-Qahtani, Ebtesam Al-Olayan, Fatimah Gh. Albani, Rania Saad Suliman, Nada Hamad Aljarba, E.M. Al-Humaidhi, Alanood S. Almurshedi, Dalia Mostafa Domiaty, Manal Abdullah Alduwish, Aljohara M. Al-Otaibi, Abdelbaset Mohamed Elasbali, Hussain Gadelkarim Ahmed, Bassam Ahmed Almutlaq
Published 2020-08-01

Screening for PIK3CA mutations among Saudi women with ovarian cancer

by Wedad Saeed Al-Qahtani, Manal Abduallah Alduwish, Ebtesam M Al-Olayan, Nada Hamad Aljarba, Al-Humaidhi Em, Fatimah Gh. Albani, Dalia Mostafa Domiaty, Aljohara M. Al-Otaibi, Somaya M. Al Qattan, Alanood S. Almurshedi, Abdelbaset Mohamed Elasbali, Hussain Gadelkarim Ahmed, Bassam Ahmed Almutlaq
Published 2021-10-01

Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia

by Nila J. Dharan, Sarah C. Sasson, Golo Ahlenstiel, Christopher R. Andersen, Mark Bloch, Griselda Buckland, Nada Hamad, Win Min Han, Anthony D. Kelleher, Georgina V. Long, Gail V. Matthews, Michael M. Mina, Emmanuelle Papot, Kathy Petoumenos, Sanjay Swaminathan, Barbara Withers, James Yun, Mark N. Polizzotto
Published 2023-01-01

P1117: GLOFITAMAB PLUS R-CHOP OR POLATUZUMAB VEDOTIN-R-CHP IS DELIVERABLE AND YIELDS HIGH OVERALL RESPONSE IN PATIENTS <=65 YEARS OF AGE WITH HIGH-RISK DLBCL OR HGBL: INTERIM ANALY...

by Adrian Minson, Emma Verner, Pratyush Giri, Shu Min Wong, Sumita Ratnasingam, Jason Butler, Wojciech Janowski, Matthew Ku, Chan Cheah, Mark Hertzberg, Kirsten Herbert, Nada Hamad, Costas Yannakou, Paul Neeson, Javad Saghebi, Piers Blombery, Molly Robertson, Lei Shong Lau, Jing Xie, John Seymour, Michael Dickinson
Published 2023-08-01

P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REG...

by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoff Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A Hawkes
Published 2023-08-01

Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia.

by Nila J Dharan, Sarah C Sasson, Golo Ahlenstiel, Christopher R Andersen, Mark Bloch, Griselda Buckland, Nada Hamad, Win Min Han, Anthony D Kelleher, Georgina V Long, Gail V Matthews, Michael M Mina, Emmanuelle Papot, Kathy Petoumenos, Sanjay Swaminathan, Barbara Withers, James Yun, Mark N Polizzotto, CORIA Study Group
Published 2023-01-01

Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases...

by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A. Hawkes
Published 2024-04-01

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

by Daphne Day, Lisa Grech, Mike Nguyen, Nathan Bain, Alastair Kwok, Sam Harris, Hieu Chau, Bryan Chan, Richard Blennerhassett, Louise Nott, Nada Hamad, Annette Tognela, David Hoffman, Amelia McCartney, Kate Webber, Jennifer Wong, Craig Underhill, Brett Sillars, Antony Winkel, Mark Savage, Bao Sheng Loe, Daniel Freeman, Eva Segelov, on behalf of the CANVACCS, DIABVACCS and MSVACCS Investigators
Published 2022-05-01

Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lym...

by Stephen Boyle, Joshua W. D. Tobin, Jacinta Perram, Nada Hamad, Veena Gullapalli, Allison Barraclough, Lydia Singaraveloo, Min-Hi Han, Richard Blennerhassett, Niles Nelson, Anna M. Johnston, Dipti Talaulikar, Krishna Karpe, Abir Bhattacharyya, Chan Yoon Cheah, Elango Subramoniapillai, Waqas Bokhari, Cindy Lee, Eliza A. Hawkes, Andrew Jabbour, Simone I. Strasser, Steven J. Chadban, Christina Brown, Peter Mollee, Greg Hapgood
Published 2021-11-01

The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study

by Josée M. Zijlstra, George Follows, Rene-Olivier Casasnovas, Joost S. P. Vermaat, Nagesh Kalakonda, Sylvain Choquet, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, John Kuruvilla, Nada Hamad, Ulrich Jaeger, Paolo Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan-Manuel Sancho, Michael Schuster, Miklos Egyed, Fritz Offner, Theodoros P. Vassilakopoulos, Priyanka Samal, Matthew Ku, Jenny Xu, Kelly Corona, Kamal Chamoun, Jatin Shah, Miguel Canales, Marie Maerevoet
Published 2022-02-01

Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance

by Allison Barraclough, James T. England, Diego Villa, Joel Wight, Greg Hapgood, Jason Conn, Nicole Wong Doo, Eric Wenlong Li, Michael Gilbertson, Briony Shaw, Mark J. Bishton, Malik Saeed, Sumita Ratnasingam, Chathuri Abeyakoon, Geoff Chong, Shin Hnin Wai, Matthew Ku, Hui-Peng Lee, Kathryn Fleming, Constantine Tam, Genevieve Douglas, Chan Y. Cheah, Zi Yun Ng, Tukten Rolfe, Anthony K Mills, Nada Hamad, Helen Cashman, Mary Gleeson, Manjunath Narayana, Eliza A. Hawkes
Published 2023-02-01

Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study

by Marie Maerevoet, Josee M. Zijlstra, George Follows, Rene-Olivier Casasnovas, J. S. P. Vermaat, Nagesh Kalakonda, Andre Goy, Sylvain Choquet, Eric Van Den Neste, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, John Kuruvilla, Nada Hamad, Ulrich Jaeger, Paolo Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan-Manuel Sancho, Michael Schuster, Miklos Egyed, Fritz Offner, Theodoros P. Vassilakopoulos, Priyanka Samal, Matthew Ku, Xiwen Ma, Kelly Corona, Kamal Chamoun, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Miguel Canales
Published 2021-07-01